Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
Add more filters










Publication year range
1.
Infect Disord Drug Targets ; 6(1): 17-29, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16787301

ABSTRACT

Of the 30 compounds currently marketed in the United States for treatment of viral infections, 15 are nucleoside analogs, demonstrating the utility of this class of compound as a source of antiviral drugs. The success of nucleoside analogs in treating other viral infections provides a compelling rationale for the significant effort that is currently being devoted to the discovery and development of nucleoside analogs to treat infection by hepatitis C virus (HCV) that may lead to improvements in response rates compared to currently available therapies. Several different approaches have been adopted to identify promising analogs, including the use of surrogate viruses in cell culture assays, screening in the cell-based bicistronic HCV replicon assay, and screening nucleoside triphosphates for the ability to inhibit the activity of the HCV RNA-dependent RNA polymerase in vitro. Several classes of ribonucleoside analogs with modifications of the ribose inhibit HCV replication. Nucleoside analogs incorporating a 2'-C-methyl modification are potent inhibitors in the replicon assay in the absence of cytotoxicity, and appear to exert their inhibition by acting as functional chain terminators of RNA synthesis. NM283, a prodrug of 2'-C-methylcytidine, has entered clinical trials and demonstrated viral load reductions in subjects infected with genotype 1 HCV, a genotype known to be difficult to treat effectively with currently approved therapies. Overall, results to date offer encouragement that improved therapies to treat HCV infection including newly developed nucleoside analogs may become available within the next few years.


Subject(s)
Antiviral Agents/pharmacology , Hepacivirus/drug effects , Nucleic Acid Synthesis Inhibitors/pharmacology , Nucleosides/pharmacology , RNA, Viral/biosynthesis , RNA-Dependent RNA Polymerase/antagonists & inhibitors , Viral Nonstructural Proteins/antagonists & inhibitors , Virus Replication/drug effects , Animals , Antiviral Agents/therapeutic use , Clinical Trials as Topic , Drug Resistance, Viral , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Hepacivirus/enzymology , Hepatitis C/drug therapy , Humans , Models, Molecular , Molecular Structure , Nucleic Acid Synthesis Inhibitors/therapeutic use , Nucleosides/therapeutic use , Protein Conformation , RNA-Dependent RNA Polymerase/metabolism , Ribonucleosides/pharmacology , Ribonucleosides/therapeutic use , Structure-Activity Relationship , Viral Nonstructural Proteins/metabolism
2.
J Am Diet Assoc ; 101(10): 1181-8, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11678489

ABSTRACT

OBJECTIVE: To examine the effect habitual physical activity has on resting metabolic rate (RMR) and body composition (fat-free mass[FFM], fat mass, and percent body fat) in active compared to sedentary adult women. DESIGN: RMR was measured (by indirect calorimetry) twice after a 12-hour fast at the same point of the menstrual cycle and 48 hours after exercise. FFM, fat mass and percent body fat were measured using whole body air displacement plethysmography. Energy intake and expenditure were determined using 7-day weighed-food records and activity logs. SUBJECTS: Healthy, weight-stable premenopausal women aged 35 to 50 years classified as either active (approximately 9 hours per week of physical activity for 10 or more years) (n= 18) or sedentary (approximately 1 hour per week of physical activity) (n= 14). STATISTICAL ANALYSES: Analysis of covariance was used to investigate differences in mean RMR (kcal/day) between the groups adjusted for FFM, and independent t tests were used to determine differences in demographic, energy expenditure, and diet variables. RESULTS: Percent body fat and fat mass were lower (P<.0005) and RMR (adjusted for FFM) was significantly higher in the active women (P=.045) compared with sedentary controls. In the active and sedentary groups respectively, mean adjusted RMR was 1,510 kcal/day and 1,443 kcal/day, body fat was 18.9% and 28.8%, and fat mass was 11.1 kg and 18.8 kg. Groups were similar in body mass, FFM, body mass index, and age. Mean energy balance appeared to be more negative in the active group (P=.0059) due to significantly higher mean self-reported energy expenditures (P=.0001) and similar mean self-reported energy intakes (P=.52) compared with sedentary controls. These data indicate that active women who participate in habitual physical activity can maintain lower body fat and a higher RMR than sedentary controls with similar body mass, FFM, and body mass index. APPLICATIONS/CONCLUSIONS: This research supports and emphasizes the benefits of habitual physical activity in maintaining RMR and lower body fat levels in middle-aged women.


Subject(s)
Basal Metabolism/physiology , Body Composition/physiology , Exercise/physiology , Adipose Tissue , Adult , Analysis of Variance , Body Mass Index , Body Weight , Calorimetry, Indirect , Diet Records , Energy Intake , Energy Metabolism/physiology , Female , Human Activities , Humans , Life Style , Middle Aged
3.
Anal Biochem ; 290(2): 214-20, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11237322

ABSTRACT

Innovations in detection technologies have allowed us to develop a novel assay in 1536-well plate format and assess the advantages of screen miniaturization compared with conventional high-throughput compound screening in 96- or 384-well plates. An HCV RNA polymerase assay has been miniaturized in 1536-well plates by using a new detection technology known as LEADseeker homogeneous imaging system. It uses a -102 degrees C cooled charge-coupled device (CCD) camera and newly designed scintillation proximity microparticles. The miniaturized assay used europium-doped streptavidin-coated yttrium oxide (YO(x)) or polystyrene (PS) microspheres to capture biotin-labeled [(3)H]RNA product transcripts. Beads in proximity to the radioisotope convert the emitted beta(-) particles into photons having wavelengths in the red region of the visible spectrum, optimal for detection by the CCD camera. Because the camera collects light from all wells of the plate simultaneously, 1536-well plates are imaged as rapidly as 384-well plates, on the order of 10 min per plate. The assay has a signal to background of approximately 20-fold, satisfactory for high-throughput robotics screening. The enzyme kinetics and potency of a known inhibitor were similar to those obtained from the conventional assay using scintillation proximity assay (SPA) beads and a scintillation plate counter. Furthermore, the newly developed microbeads (emitting at 610 to 620 nm) are less prone to quenching effects caused by yellow-colored compounds, than conventional SPA beads or scintillation fluid (emitting at 400 to 480 nm region). Thus, the LEADseeker imaging system is a useful new tool for miniaturization of assays for high-throughput screening.


Subject(s)
DNA-Directed RNA Polymerases/analysis , Diagnostic Imaging/methods , Hepacivirus/enzymology , Cold Temperature , DNA-Directed RNA Polymerases/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Inhibitory Concentration 50 , Scintillation Counting/methods , Signal Transduction
4.
J Neurosci ; 21(1): 330-9, 2001 Jan 01.
Article in English | MEDLINE | ID: mdl-11150350

ABSTRACT

Chronic stressors produce changes in hippocampal neurochemistry, neuronal morphology, and hippocampal-dependent learning and memory processes. In rats, stress-induced changes in CA3 apical dendritic structure are mediated by corticosterone (CORT) acting, in part, on excitatory amino acid neurotransmission. CORT also alters GABA-mediated inhibitory neurotransmission, so the GABA(A) receptor system may also contribute to dendritic remodeling and other stress-related changes in hippocampal function. A previous study indicated that chronic CORT treatment produces complex changes in GABA(A) receptor subunit mRNA levels, so we hypothesized that CORT alters the pharmacological properties of hippocampal GABA(A) receptors. To test this, adult male rats were treated with CORT or vehicle pellets for 10 d, after which we quantified [(35)S]t-butylbicyclophosphorothionate ([(35)S]TBPS) and [(3)H]flunitrazepam binding to GABA(A) receptors using in vitro receptor autoradiography. Pharmacological properties of receptors were assessed by examining the allosteric regulation of binding at both sites by GABA and 5alpha-pregnane-3alpha,21-diol-20-one (THDOC), an endogenous anxiolytic steroid. We found striking regional differences in the modulation of [(35)S]TBPS binding, particularly between strata radiatum and strata oriens, suggesting a functional heterogeneity among hippocampal GABA(A) receptors even within the apical versus basal dendrites of pyramidal neurons. Furthermore, we found that CORT treatment decreased the negative modulation of hippocampal [(35)S]TBPS binding by both GABA and THDOC and increased the enhancement of [(3)H]flunitrazepam binding by GABA and THDOC in the dentate gyrus. Together, these data suggest that prolonged exposure to stress levels of corticosteroids may alter hippocampal inhibitory tone by regulating the pharmacological properties of GABA(A) receptors in discrete dendritic subfields.


Subject(s)
Corticosterone/metabolism , Desoxycorticosterone/analogs & derivatives , Hippocampus/metabolism , Receptors, GABA-A/metabolism , Allosteric Regulation/drug effects , Animals , Autoradiography , Binding, Competitive/drug effects , Bridged Bicyclo Compounds, Heterocyclic/pharmacokinetics , Corticosterone/administration & dosage , Dendrites/metabolism , Desoxycorticosterone/pharmacology , Drug Implants , Flunitrazepam/pharmacokinetics , Hippocampus/cytology , Hippocampus/drug effects , Ligands , Male , Rats , Rats, Sprague-Dawley , gamma-Aminobutyric Acid/metabolism , gamma-Aminobutyric Acid/pharmacology
5.
Biochemistry ; 39(28): 8243-9, 2000 Jul 18.
Article in English | MEDLINE | ID: mdl-10889032

ABSTRACT

The enzymatic activity of a C-terminally truncated form of the RNA-dependent RNA polymerase, termed NS5B(Delta21), of the hepatitis C virus (strain BK) has been investigated using both homopolymeric and heteropolymeric RNA templates. Incorporation of nucleotides into a heteropolymeric RNA template as catalyzed by NS5B(Delta21) is characterized by biphasic reaction time courses. At high concentrations of nucleoside triphosphate in reactions allowing a preincubation of NS5B(Delta21) and RNA template, an initial rapid phase of the reaction is followed by a slower linear phase. The amplitude of the first phase of the reaction varies directly with the concentration of the enzyme in the reaction. It is shown here that full-length copies of the template are produced during the first phase of the reaction. Our results reveal that NS5B(Delta21) is processive but only a small fraction, less than 1%, of the purified enzyme present participates productively in the reaction. Most importantly, the turnover number for the hepatitis C NS5B(Delta21) is comparable to those observed for other polymerases such as the HIV-1 reverse transcriptase. The combined results reconcile in part the apparent discrepancy of the low, observed specific activity of the purified enzyme and the rapid generation of HCV in vivo.


Subject(s)
Hepacivirus/enzymology , RNA-Dependent RNA Polymerase/metabolism , Catalysis , Gene Deletion , Hepacivirus/physiology , RNA-Dependent RNA Polymerase/genetics , RNA-Dependent RNA Polymerase/isolation & purification , Reaction Time , Templates, Genetic , Virus Replication
6.
J Biol Chem ; 272(31): 19187-92, 1997 Aug 01.
Article in English | MEDLINE | ID: mdl-9235909

ABSTRACT

Ribonuclease L (RNase L) is an endoribonuclease that is activated upon binding of adenosine oligomers linked 2' to 5' to cleave viral and cellular RNAs. We recently proposed a model for activation in which activator A binds to monomer, E, to form EA, which subsequently dimerizes to the active form, E2A2 (Cole, J. L., Carroll, S. S., and Kuo, L. C. (1996) J. Biol. Chem. 271, 3978-3981). Here, we have employed this model to define the equilibrium constants for activator binding (Ka) and dimerization of EA to E2A2 (Kd) by equilibrium analytical ultracentrifugation and fluorescence measurements. Multi-wavelength sedimentation data were globally fit to the model above, yielding values of Ka = 1.69 microM and Kd = 17. 8 nM for 2',5'-linked adenosine trimer. Fluorescent conjugates of 2',5'-linked adenosine trimer with 7-hydroxycoumarin have been prepared. The coumarin emission anisotropy shows a large increases upon binding to RNase L. Analysis of anisotropy titrations yields values of Ka and Kd close to those obtained by sedimentation. The sedimentation parameters for unmodified 2',5'-linked adenosine trimer also agree with those obtained by enzyme kinetic methods (Carroll, S. S., Cole, J. L., Viscount, T., Geib, J., Gehman, J., and Kuo, L. C. (1997) J. Biol. Chem. 272, 19193-19198). Thus, the data presented here clearly define the energetics of RNase L activation and support the minimal activation model.


Subject(s)
Adenine Nucleotides/pharmacology , Endoribonucleases/chemistry , Oligoribonucleotides/pharmacology , Endoribonucleases/metabolism , Enzyme Activation , Fluorescence Polarization , Humans , Kinetics
7.
J Biol Chem ; 272(31): 19193-8, 1997 Aug 01.
Article in English | MEDLINE | ID: mdl-9235910

ABSTRACT

Ribonuclease L (RNase L), the 2',5'-oligoadenylate-dependent ribonuclease, is one of the cellular antiviral systems with enhanced activity in the presence of interferon. A reaction scheme has been developed to model the sequence of steps necessary for the activation of RNase L (Cole, J. L., Carroll, S. S., Blue, E. S., Viscount, T., and Kuo, L. C. (1997) J. Biol. Chem. 272, 19187-19192). The model comprises three sequential binding steps: the binding of activator to enzyme monomer, the subsequent dimerization of the activated monomer to form the active enzyme dimer, followed by the binding of substrate prior to catalysis. The model is used to evaluate the activation of RNase L by several synthetic analogs of the native activator. The 5'-phosphate of the activator has been determined to be an important structural determinant for the efficient activation of RNase L, and its loss caused a loss of activator affinity of 2-3 orders of magnitude. The length of activator is not an important determinant of activator potency for the activator analogs examined. The specific activity of the enzyme under conditions of saturation of activator binding and complete dimerization of the activated monomers varies only by about a factor of 3 for the activators examined, indicating that once dimerized in the presence of any of these activators, the enzyme exhibits a similar catalytic activity.


Subject(s)
Adenine Nucleotides/pharmacology , Oligoribonucleotides/pharmacology , Ribonucleases/metabolism , Dimerization , Enzyme Activation , Humans , Kinetics , Ribonucleases/chemistry
8.
J Biol Chem ; 271(9): 4988-92, 1996 Mar 01.
Article in English | MEDLINE | ID: mdl-8617774

ABSTRACT

RNase L, the 2',5' oligoadenylate-dependent ribonuclease, is one of the enzyme systems important in the cellular response to interferon. When activated in the presence of 2',5'-linked oligoadenylates, RNase L can catalyze the cleavage of synthetic oligoribonucleotides that contain dyad sequences of the forms UU, UA, AU, AA, and UG, but it cannot catalyze the cleavage of an oligoribonucleotide containing only cytosines. The primary site of the cleavage reaction with the substrate C11UUC7 has been defined to be 3' of the UU dyad by labeling either the 5' or the 3' end of the oligoribonucleotide and by examining the reaction products on polyacrylamide sequencing gels. Reaction time courses have been used to determine the kinetic parameters of the cleavage reactions. The effect of the overall length of the oligomeric substrate as well as the sequence of the bases around the position of the cleavage site on the kinetics of the cleavage reaction has been examined. The efficiency with which activated RNase L catalyzes the cleavage of the substrate C11UUC7 is 1.9 x 10(7) m-1 s-1. Because the cleavage of the synthetic oligoribonucleotide can be used to monitor the steady-state kinetics of catalysis by activated RNase L, this method offers an advantage over previous methods of assay for RNase L activity.


Subject(s)
Endoribonucleases/metabolism , Oligoribonucleotides/metabolism , Adenine Nucleotides/pharmacology , Animals , Base Sequence , Cell Line , Cloning, Molecular , DNA Primers , Enzyme Activation , Humans , Insecta , Kidney/enzymology , Kinetics , Molecular Sequence Data , Oligoribonucleotides/chemistry , Oligoribonucleotides/pharmacology , Polymerase Chain Reaction , Recombinant Proteins/metabolism , Substrate Specificity , Transfection
9.
J Biol Chem ; 271(8): 3979-81, 1996 Feb 23.
Article in English | MEDLINE | ID: mdl-8626728

ABSTRACT

Ribonuclease L is an endoribonuclease that is activated by binding of 2',5'-linked oligoadenylates. Activation of ribonuclease L also induces dimerization. Here, we demonstrate using equilibrium sedimentation that dimerization requires the binding of one 5'-monophosphate 2',5'-(adenosine)3 molecule per ribonuclease L monomer. No dimerization was observed in the absence of activator up to a protein concentration of 18 microM, indicating that unliganded enzyme is unable to dimerize or the association is very weak. In parallel with dimerization, enzymatic activity is also maximized at a 1:1 activator: ribonuclease L stoichiometry. The same stoichiometry for dimerization is observed using a nonphosphorylated activator 2'-5'-(adenosine)3. Adenosine triphosphate or RNA oligonucleotide substrates do not induce dimerization. The observed stoichiometry supports a model for ribonuclease L dimerization in which activator binds to monomer, which subsequently dimerizes.


Subject(s)
Adenine Nucleotides/pharmacology , Antiviral Agents/pharmacology , Endoribonucleases/chemistry , Endoribonucleases/metabolism , Oligoribonucleotides/pharmacology , Adenosine Triphosphate/pharmacology , Endoribonucleases/drug effects , Humans , Kinetics , Macromolecular Substances , Models, Theoretical , Recombinant Proteins/chemistry , Recombinant Proteins/drug effects , Recombinant Proteins/metabolism
11.
Antimicrob Agents Chemother ; 39(12): 2602-5, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8592986

ABSTRACT

The clinical benefit of the human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) is limited by the rapid selection of inhibitor-resistant viral variants. However, it may be possible to enhance the clinical utility of this inhibitor class by deriving compounds that express both high levels of antiviral activity and an augmented pharmacokinetic profile. Accordingly, we developed a new class of NNRTIs, the 1, 4-dihydro-2H-3, 1-benzoxazin-2-ones. L-743, 726 (DMP-266), a member of this class, was chosen for clinical evaluation because of its in vitro properties. The compound was a potent inhibitor of the wild-type HIV-1 RT (Ki = 2.93 nM) and exhibited a 95% inhibitory concentration of 1.5 nM for the inhibition of HIV-1 replicative spread in cell culture. In addition, L-7743, 7726 was found to be capable of inhibiting, with 95% inhibitory concentrations of < or = 1.5 microM, a panel of NNRTI-resistant mutant viruses, each of which expressed a single RT amino acid substitution. Derivation of virus with notably reduced susceptibility to the inhibitor required prolonged cell culture selection and was mediated by a combination of at least two RT amino acid substitutions. Studies of L-743, 726 in rats, monkeys, and a chimpanzee demonstrated the compound's potential for good oral bioavailability and pharmacokinetics in humans.


Subject(s)
Antiviral Agents/pharmacology , HIV-1/enzymology , Oxazines/pharmacology , RNA-Directed DNA Polymerase/metabolism , Reverse Transcriptase Inhibitors/pharmacology , Alkynes , Animals , Antiviral Agents/pharmacokinetics , Benzoxazines , Biological Availability , Cell Line , Crystallography, X-Ray , Cyclopropanes , Drug Resistance, Microbial , HIV Reverse Transcriptase , HIV-1/drug effects , Half-Life , Humans , Macaca mulatta , Male , Molecular Structure , Oxazines/pharmacokinetics , Pan troglodytes , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Inhibitors/pharmacokinetics , T-Lymphocytes/virology
12.
J Am Diet Assoc ; 95(11): 1280-7, 1995 Nov.
Article in English | MEDLINE | ID: mdl-7594124

ABSTRACT

OBJECTIVE: To compare the blood pressure responses of men with hypertension consuming low-sodium (Na) metabolic diets differing in dietary calcium (Ca) for two 6-week periods. SUBJECTS: White men who had hypertension, were nonsmokers, and were sedentary. INTERVENTION: This study consisted of two separate 6-week metabolic feeding periods. In the first period, a high-Ca group (n = 6) was fed 1,400 mg Ca per day. In the second period, a low-Ca group (n = 5) was fed 400 mg Ca per day. Both groups were fed 1,500 mg Na per day. MAIN OUTCOME MEASURES: Blood pressure; urine and blood measured for electrolyte, calcitriol, renin, and parathyroid hormone (PTH) levels. To measure typical nutrient intakes, 3-day dietary records were collected before the beginning of each treatment period. STATISTICAL ANALYSES PERFORMED: Repeated-measures analysis of variance and split-plot analysis of variance were used to analyze, respectively, blood pressure responses and response variables over time. RESULTS: In both groups, serum Na level decreased (P < .05) over the 6-week period; urine Na decreased (P < .05) only in the low-Ca group. Serum PTH level decreased (P < .05) in the high-Ca group and increased (P < .05) in the low-Ca group; no change occurred in serum calcitriol level. Diastolic blood pressure decreased (8 mm Hg) in the low-Ca group (P < .05). The low-Ca group showed an 8% to 9% decrease in both systolic and diastolic blood pressure vs a 2% to 3% decrease in the high-Ca group. We also examined how the metabolic diet differed from subjects' typical diet. Results showed a positive correlation between the change in Na intake (usual to metabolic diet) and the change in systolic and diastolic blood pressure in both groups (P < .04). Results also showed a negative correlation between the change in the ratio of Na to Ca (usual to metabolic diet) and the change in diastolic blood pressure in the low-Ca group (P < .03). Directional change in blood pressure (either increase or decrease) could be predicted on the basis of how much the Na and Ca in the metabolic diet differed from subject's typical diet. APPLICATIONS: Results of this study suggest that in the dietary management of hypertension it may be more important to focus on specific changes in a person's diet (eg, decreasing Na intake by 1,000 mg/day and increasing Ca intake by 400 mg/day) rather than setting specific levels of Na and Ca to be consumed.


Subject(s)
Blood Pressure/physiology , Calcium, Dietary/standards , Diet, Sodium-Restricted/standards , Hypertension/diet therapy , Analysis of Variance , Body Weight/physiology , Calcium/blood , Calcium/urine , Calcium, Dietary/administration & dosage , Energy Intake , Humans , Hypertension/metabolism , Hypertension/physiopathology , Male , Middle Aged , Parathyroid Hormone/blood , Parathyroid Hormone/urine , Renin/blood , Renin/urine , Sodium/blood , Sodium/urine , Time Factors , White People
13.
J Biol Chem ; 269(51): 32351-7, 1994 Dec 23.
Article in English | MEDLINE | ID: mdl-7528214

ABSTRACT

6-Chloro-(4S)-cyclopropyl-3,4-dihydro-4-((2-pyridyl)-ethynyl)quinazol in- 2(1H)-one (L-738,372) is representative of a novel structural class of nonnucleoside inhibitors of human immunodeficiency virus, strain 1 (HIV-1), reverse transcriptase (RT), the quinazolinones. L-738,372 is a reversible inhibitor of HIV-1 RT and is noncompetitive against dTTP with a Ki of 140 nM with poly(rA).oligo(dT) as primer-template. Mixed noncompetitive inhibition by L-738,372 was observed against poly(rC).oligo(dG) as primer-template. This quinazolinone binds to RT at a site that overlaps the binding site of other nonnucleoside inhibitors as evidenced by the ability of L-738,372 to displace bound radiolabeled L-696,229, a member of the pyridinone class of inhibitors of HIV-1 RT, from complexes of RT and primer-template. Inhibition by L-738,372 shows slow binding characteristics in reactions with all of the primer-templates employed. Synergistic inhibition of RT activity was evident in combinations of L-738,372 and any of the nucleoside analogs, azidothymidine triphosphate, dideoxyinosine triphosphate, or dideoxycytosine triphosphate. The azidothymidine-resistant form of RT (D67N, K70R, T215Y, K219Q) is inhibited by L-738,372 with 2-3-fold more potency than is the wild-type RT. Comparison of inhibition by L-738,372 with inhibition by pyridinone inhibitors reveals differences in synergistic inhibition with nucleoside analogs and in the rates of binding of the inhibitors.


Subject(s)
HIV-1/enzymology , Nucleosides/pharmacology , Pyridones/pharmacology , Quinazolines/pharmacology , Reverse Transcriptase Inhibitors , Binding Sites , DNA Primers , Drug Resistance , Drug Synergism , HIV Reverse Transcriptase , Protein Binding , Quinazolinones , RNA-Directed DNA Polymerase/metabolism , Templates, Genetic , Zidovudine/pharmacology
14.
Nucleic Acids Res ; 22(8): 1437-43, 1994 Apr 25.
Article in English | MEDLINE | ID: mdl-7514786

ABSTRACT

The importance of RNA secondary structure on HIV-1 reverse transcriptase catalyzed polymerization and on the potency of the pyridin-2-one inhibitor 3-(4,7-dichlorobenzoxazol-2-ylmethylamino)-5-ethyl-6-meth ylpyridin-2(1H)-one, L-697,661, were investigated by employing heteromeric primer-template systems. Our data revealed that a stem-loop hairpin secondary structure in the RNA template could lead to strong hindrance of reverse transcription in the reaction catalyzed by HIV-1 reverse transcriptase resulting in the build up of intermediate-length (pause) polymerization products. The presence of L-697,661 greatly enhanced the accumulation of the pause products suggesting that the rate of enzyme translocation from the pause product might be more potently inhibited than polymerization up to the pause site. Model experiments using a synthetic RNA template containing a stem-loop hairpin revealed that the inhibitory potency of L-697, 661 increased 2-fold upon polymerization to within four bases of the secondary structure. Inhibitor potency was enhanced over 6-fold when primer-extension proceeded through the duplex region of the stem-loop.


Subject(s)
Antiviral Agents/pharmacology , Benzoxazoles/pharmacology , Nucleic Acid Conformation , Pyridones/pharmacology , RNA, Viral/drug effects , Reverse Transcriptase Inhibitors , Animals , Base Sequence , DNA Primers , Electrophoresis, Polyacrylamide Gel , Globins/genetics , HIV Reverse Transcriptase , Molecular Sequence Data , Molecular Structure , RNA, Viral/chemistry , Rabbits , Templates, Genetic
15.
Biochemistry ; 33(8): 2113-20, 1994 Mar 01.
Article in English | MEDLINE | ID: mdl-7509634

ABSTRACT

HIV-1 reverse transcriptase can catalyze the addition of either azidothymidine monophosphate (AZTMP) or thymidine monophosphate (dTMP) to a primer strand opposite template adenosine bases. The ratio of incorporation of AZTMP to dTMP as catalyzed by HIV-1 reverse transcriptase has been determined to be 0.4 using an RNA-DNA duplex substrate prepared from oligonucleotides with sequences taken from the HIV-1 genome sequence. Slight variations are found for the incorporation ratio of the two nucleotides on other substrates. Substrates containing more than one adenosine in the single-stranded part of the template allow for more chances to incorporate AZTMP and less full-length product. Variations in the intensity of bands on an autoradiograph of a DNA sequencing gel corresponding to different positions of incorporation of AZTMP suggest that not all template adenosine positions offer the same level of discrimination against incorporation of AZTMP. A reverse transcriptase containing a set of four mutations (D67N, K70R, T215Y, K219Q) known to cause resistance to AZT in cell culture assays has a ratio of incorporation that is 0.77 +/- 0.03 times the ratio for the wild-type reverse transcriptase opposite one specific template adenosine. In contrast, a hybrid mutant containing the same four mutations that cause resistance to AZT and an additional mutation, Y181C, which by itself causes resistance to the non-nucleoside inhibitor L-697,661 [Sardana et al. (1992), J. Biol. Chem. 267, 17526-17530], has a ratio of incorporation that is 1.34 +/- 0.01 times that of the wild-type, indicating that the hybrid mutant enzyme is more susceptible to inhibition by AZTTP than the wild-type reverse transcriptase.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Antiviral Agents/pharmacology , HIV-1/enzymology , Mutation , Reverse Transcriptase Inhibitors , Thymine Nucleotides/pharmacology , Zidovudine/analogs & derivatives , Base Sequence , DNA Primers , Dideoxynucleotides , Diphosphates/metabolism , HIV Reverse Transcriptase , Hydrolysis , Molecular Sequence Data , Mutagenesis, Site-Directed , RNA-Directed DNA Polymerase/genetics , RNA-Directed DNA Polymerase/metabolism , Substrate Specificity , Templates, Genetic , Thymidine Monophosphate/metabolism , Thymine Nucleotides/metabolism , Zidovudine/metabolism , Zidovudine/pharmacology
16.
J Biol Chem ; 268(1): 276-81, 1993 Jan 05.
Article in English | MEDLINE | ID: mdl-7677997

ABSTRACT

The inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by pyridinone compounds has been investigated using as templates synthetic RNA with sequences based on the HIV-1 genome sequence. In reactions catalyzed by the enzyme that incorporated more than one nucleotide per primer, inhibition by a representative pyridinone inhibitor, 3-[2-(1,3-benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-pyridin-2(1H)one (L-696,229), was noncompetitive against deoxynucleotide triphosphate. For reactions that incorporated one deoxynucleotide per primer, IC50 values ranged from 20 to 200 nM, depending on the position of incorporation of the incoming deoxynucleotide base on the template. Inhibition of synthesis on a set of four templates differing only at the template base complementary to the incoming nucleotide had similar IC50 values. These results demonstrate that inhibitory potency is dependent on the primary structure of the template and that inhibitory potency is largely independent of the identity of the incoming nucleotide base. The inhibition of HIV-1 reverse transcription by L-696,229 also displayed slow-binding characteristics. The slow-binding aspect was exploited to gauge the interaction between inhibitor and enzyme. By titrating the reduction in the extent of the burst of synthesis observed in a reaction incorporating dideoxythymidine monophosphate into poly(rA)-oligo(dT)18, the apparent equilibrium constant for dissociation of the reverse transcriptase-L-696,229 complex was estimated to be 400 nM.


Subject(s)
Antiviral Agents/pharmacology , Benzoxazoles/pharmacology , HIV-1/enzymology , Oligodeoxyribonucleotides/pharmacology , Pyridones/pharmacology , Reverse Transcriptase Inhibitors , Base Sequence , Cloning, Molecular , Escherichia coli/genetics , HIV Reverse Transcriptase , Kinetics , Molecular Sequence Data , Oligodeoxyribonucleotides/metabolism , Recombinant Proteins/antagonists & inhibitors , Structure-Activity Relationship , Templates, Genetic
17.
Am J Clin Nutr ; 54(1): 41-6, 1991 Jul.
Article in English | MEDLINE | ID: mdl-2058585

ABSTRACT

The purpose of this research was to determine if resting energy expenditure (REE) and exercise energy expenditure (EEE) differed between nonobese female cyclical dieters (n = 11) and nondieting control subjects (n = 12). Dieters were defined as having intermittent periods of caloric restriction (less than or equal to 4184 kJ/d, or less than or equal to 1000 kcal/d) for greater than or equal to 7-10 d four times in the preceding year. Dieters were significantly (P less than 0.01) heavier (66 vs 57 kg) and fatter (26% vs 21% body fat) than controls subjects whereas fat-free tissue was similar in both groups. Dieters had significantly (P less than 0.003) lower relative REE than did control subjects (2.8 vs 3.1 mL O2.kg-1.min-1; 79 vs 92 kJ.kg body wt-1.d-1, or 19 vs 22 kcal.kg body wt-1.d-1) but absolute REE (kJ/d, or kcal/d) was similar. Regardless of the workload examined, relative EEE was significantly (P less than 0.009) lower in dieters than in control subjects whereas absolute EEEs were similar at each workload. Results indicate an increased efficiency of food utilization during exercise in dieters but no difference in absolute REE. In addition, repeated bouts of dieting may alter body composition.


Subject(s)
Basal Metabolism , Diet, Reducing , Energy Metabolism , Physical Exertion/physiology , Adipose Tissue/anatomy & histology , Adult , Calorimetry, Indirect , Eating , Female , Humans , Oxygen Consumption , Periodicity , Weight Gain/physiology , Weight Loss/physiology
18.
Biochemistry ; 30(5): 1441-8, 1991 Feb 05.
Article in English | MEDLINE | ID: mdl-1991125

ABSTRACT

Inhibition of the pre-steady-state burst of nucleotide incorporation by a single incorrect nucleotide (nucleotide discrimination) was measured with the Klenow fragment of DNA polymerase I [KF(exo+)]. For the eight mispairs studied on three DNA sequences, only low levels of discrimination ranging from none to 23-fold were found. The kinetics of dNTP incorporation into the 9/20-mer at low nucleotide concentrations was also determined. A limit of greater than or equal to 250 s-1 was placed on the nucleotide off-rate from the KF(exo+)-9/20-dTTP complex in accord with nucleotide binding being at equilibrium in the overall kinetic sequence. The influence of the relatively short length of the 9/20-mer on the mechanism of DNA replication fidelity was determined by remeasuring important kinetic parameters on a 30/M13-mer with high homology to the 9/20-mer. Pre-steady-state data on the nucleotide turnover rates, the dATP(alpha S) elemental effect, and the burst of dAMP misincorporation into the 30/M13-mer demonstrated that the kinetics were not affected by the length of the DNA primer/template. The effects on fidelity of two site-specific mutations, KF(polA5) and KF(exo-), were also examined. KF(polA5) showed an increased rate of DNA dissociation and a decreased rate of polymerization resulting in less processive DNA synthesis. Nevertheless, with at least one misincorporation event, that of dAMP into the 9/20-mer, KF(polA5) displays an increased replication fidelity.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
DNA Polymerase I/metabolism , DNA Replication , Base Sequence , DNA Polymerase I/genetics , Deoxyribonucleotides/metabolism , In Vitro Techniques , Kinetics , Manganese/pharmacology , Molecular Sequence Data , Mutagenesis , Mutation , Oligodeoxyribonucleotides/chemistry , Structure-Activity Relationship , Templates, Genetic , Thermodynamics
19.
Biochemistry ; 30(3): 804-13, 1991 Jan 22.
Article in English | MEDLINE | ID: mdl-1899034

ABSTRACT

The kinetic parameters governing incorporation of correct and incorrect bases into synthetic DNA duplexes have been investigated for Escherichia coli DNA polymerase I [Klenow fragment (KF)] and for two mutants, Tyr766Ser and Tyr766Phe. Tyr766 is located at the C-terminus of helix O in the DNA-binding cleft of KF. The catalytic efficiency for correct incorporation of dNTP is reduced 5-fold for Tyr766Ser. The catalytic efficiencies of all 12 possible misincorporations have been determined for both KF and Tyr766Ser by using single-turnover kinetic conditions and a form of the enzyme that is devoid of the 3'-5' exonuclease activity because of other single amino acid replacements. Tyr766Ser displays an increased efficiency of misincorporation (a reduction in fidelity) for several of the 12 mismatches. The largest increase in efficiency of misincorporation for Tyr766Ser occurs for the misincorporation of TMP opposite template guanosine, a 44-fold increase. In contrast, the efficiencies of misincorporation of dAMP opposite template A, G, or C are little affected by the mutation. A determination of the kinetic parameters associated with a complete kinetic scheme has been made for Tyr766Ser. The rate of addition of the next correct nucleotide onto a preexisting mismatch is decreased for Tyr766Ser. The fidelity of Tyr766Phe was not substantially different from that of KF for the misincorporations examined, indicating that it is the loss of the phenolic ring of the side chain of Tyr766 that leads to the significant decrease in fidelity. The results indicate that KF actively participates in the reduction of misincorporations during the polymerization event and that Tyr766 plays an important role in maintaining the high fidelity of replication by KF.


Subject(s)
DNA Polymerase I/genetics , Mutation , Base Sequence , Computer Simulation , DNA/biosynthesis , DNA Replication , Escherichia coli/enzymology , Kinetics , Molecular Sequence Data , Phenylalanine/genetics , Serine/genetics , Tyrosine/genetics
20.
Am J Clin Nutr ; 50(2): 339-45, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2756921

ABSTRACT

Free-living, elderly persons (aged greater than or equal to 60 y, n = 198) were recruited to determine the effects of age, sex, health status, dietary vitamin B-6 intakes, and B-6 supplement use on plasma pyridoxal 5'-phosphate (PLP). Vitamin B-6 intakes were determined from 3-d diet records; supplementation was based on self-reported brand and frequency data. Fasting blood samples were analyzed for PLP. Subjects were primarily low-income Caucasians. There was no linear relationship between dietary vitamin B-6 intake, age, sex or health status, and PLP while accounting for supplemental vitamin B-6 use. PLP, however, was negatively correlated with age (p less than 0.001) in individuals with PLP values between 32 and 90 nmol/L. Vitamin B-6 status was low (PLP less than 32 nmol/L) in 32% of this elderly population (n = 198) and could be attributed to low dietary vitamin B-6 intakes and/or the presence of health problems reported to alter vitamin B-6 status. This research suggests that low vitamin B-6 status is prevalent in low-income, elderly persons, especially those with multiple health problems.


Subject(s)
Diet , Pyridoxal Phosphate/blood , Pyridoxine/administration & dosage , Aged , Aged, 80 and over , Aging/metabolism , Anthropometry , Female , Humans , Male , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...